Cite
HARVARD Citation
Erbe, A. et al. (2015). Associations of Fc gamma receptor (FcgR2a, FcgR3a and FcgR2c) genotype with outcome in metastatic renal cell carcinoma (mRCC) patients receiving high dose interleukin 2 (HD-IL2). Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].